Safety review of 20-valent pneumococcal conjugate vaccine

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-024-72446-0
中图分类号
学科分类号
摘要
引用
收藏
页码:9 / 9
相关论文
共 50 条
  • [31] Cost-effectiveness analysis of the 20-valent pneumococcal conjugate vaccine for the pediatric population in South Korea
    Kang, Dong-Won
    Choe, Young June
    Lee, Ju-Yeon
    Suk, In-Ae
    Kim, Young-Soo
    Kim, Hak-Yeon
    Byun, Bo-Kyung
    Park, Sun-Kyeong
    VACCINE, 2024, 42 (22)
  • [32] COST-EFFECTIVENESS OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN SINGAPOREAN ADULTS AGED $18 YEARS
    Averin, A.
    Oh, S. X.
    Vietri, J.
    Atwood, M.
    Hariharan, D.
    Huang, L.
    VALUE IN HEALTH, 2023, 26 (12) : S77 - S77
  • [33] Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions
    Mark H. Rozenbaum
    Erica Chilson
    Raymond Farkouh
    Liping Huang
    Alejandro Cane
    Adriano Arguedas
    Maria J. Tort
    Vincenza Snow
    Ahuva Averin
    Derek Weycker
    Dhwani Hariharan
    Mark Atwood
    Infectious Diseases and Therapy, 2024, 13 : 745 - 760
  • [34] Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan
    Shinjoh, Masayoshi
    Togo, Kanae
    Hayamizu, Tomoyuki
    Yonemoto, Naohiro
    Morii, Junko
    Perdrizet, Johnna
    Kamei, Kazumasa
    EXPERT REVIEW OF VACCINES, 2024, 23 (01) : 485 - 497
  • [35] Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions
    Rozenbaum, Mark H.
    Chilson, Erica
    Farkouh, Raymond
    Huang, Liping
    Cane, Alejandro
    Arguedas, Adriano
    Tort, Maria J.
    Snow, Vincenza
    Averin, Ahuva
    Weycker, Derek
    Hariharan, Dhwani
    Atwood, Mark
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (04) : 745 - 760
  • [36] Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization Practices-United States, 2022
    Kobayashi, Miwako
    Farrar, Jennifer L.
    Gierke, Ryan
    Britton, Amadea
    Childs, Lana
    Leidner, Andrew J.
    Campos-Outcalt, Doug
    Morgan, Rebecca L.
    Long, Sarah S.
    Talbot, H. Keipp
    Poehling, Katherine A.
    Pilishvili, Tamara
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (04): : 109 - 117
  • [37] Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years
    Essink, Brandon
    Sabharwal, Charu
    Cannon, Kevin
    Frenck, Robert
    Lal, Himal
    Xu, Xia
    Sundaraiyer, Vani
    Peng, Yahong
    Moyer, Lisa
    Pride, Michael W.
    Scully, Ingrid L.
    Jansen, Kathrin U.
    Gruber, William C.
    Scott, Daniel A.
    Watson, Wendy
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (03) : 390 - 398
  • [38] RAPID ADOPTION OF PNEUMOCOCCAL 20-VALENT CONJUGATE VACCINE (PCV20) VACCINATION IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Karime, Christian
    Crosby, Sheena K.
    Bhat, Shubha
    Hashash, Jana G.
    Farraye, Francis A.
    GASTROENTEROLOGY, 2023, 164 (06) : S678 - S679
  • [39] Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease
    Mendes, Diana
    Averin, Ahuva
    Atwood, Mark
    Sato, Reiko
    Vyse, Andrew
    Campling, James
    Weycker, Derek
    Slack, Mary
    Ellsbury, Gillian
    Mugwagwa, Tendai
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (08) : 1285 - 1295
  • [40] Potential Role of 20-valent Pneumococcal Conjugate Vaccine in Preventing Septic Shock in Patients Older Than 65 With Bacteremic Pneumococcal Pneumonia
    Sanz, F.
    Ruiz Iturriaga, L. A.
    Garcia Clemente, M. M.
    Espana Yandiola, P. P.
    Serrano, L.
    Carrion, N.
    Herrero Huertas, J.
    Fernandez Fabrellas, E.
    Zalacain Jorge, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207